Trinity Biotech

Trinity Biotech — FDA 510(k) Submissions

Trinity Biotech has submitted 5 FDA 510(k) premarket notifications since 2009, of which 5 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Reagent, Borrelia Serological Reagent, Giardia Spp., Cryptosporidium Spp., System, Multipurpose For In Vitro Coagulation Studies . Use the specialty filter in the sidebar to narrow results.